Clavaminate synthase (CAS), a remarkable Fe(II)/2-oxoglutarate oxygenase, c
atalyzes three separate oxidative reactions in the biosynthesis of clavulan
ic acid, a clinically used inhibitor of serine beta-lactamases, The first C
AS-catalyzed step (hydroxylation) is separated from the latter two (oxidati
ve cyclization/desaturation) by the action of an amidinohydrolase, Here, we
describe crystal structures of CAS in complex with Fe(II), 2-oxoglutarate
(2OG) and substrates (N-alpha-acetyl-L-arginine and proclavaminic acid). Th
ey reveal how GAS catalyzes formation of the clavam nucleus, via a process
unprecedented in synthetic organic chemistry, and suggest how it discrimina
tes between substrates and controls reaction of its highly reactive ferryl
intermediate. The presence of an unpredicted jelly roll beta-barrel core in
CAS implies divergent evolution within the family of 2OG and related oxyge
nases, Comparison with other non-heme oxidases/oxygenases reveals flexibili
ty in the position which dioxygen ligates to the iron, in contrast to the a
nalogous heme-using enzymes.